ICON Development Solutions has industry-recognized expertise in the application and presentation of pharmacokinetic (PK) and pharmacodynamic (PD) principles critical for successful drug approval, with experience over the past 5 years that includes the following:
Developing PK/Biopharmaceutics Strategy As Part Of The Drug Development Plan
ICON applies its scientific and regulatory expertise to developing over-arching PK/Biopharmaceutics strategy,and to designing individual PK studies and substudies to expedite the drug development process.
Performing Efficiency and Quality Analysis
ICON performs comprehensive support for pharmacokinetic analyses and reports, including:
Analyses are performed and reports are written by senior level pharmacokineticists and peer-reviewed to ensure that they are regulatory-ready.